Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*
Completed · Not applicable
Conditions studied: Idiopathic Toe Walking
In brief
To compare and contrast the clinical, gait and parent-reported outcomes following either non-operative (casting) or operative treatment for children with idiopathic toe walking (ITW) and determine whether there are specific genes associated with ITW.
Key facts
- Study ID
- NCT06305689
- Run by
- Shriners Hospitals for Children
- People needed
- 65
- Starts
- 2022-01-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2026-01-14
Who can join
Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Idiopathic Toe Walking Persistent (ITWp)
- Between the ages of 6-18 years
- Passive dorsiflexion dorsiflexion with knee extension between -10 plantar flexion - + 5 degrees of dorsiflexion, DiGiovanni defined an isolated gastrocnemius contracture as maximum passive ankle dorsiflexion as < 5 degrees with the knee in full extension
You may not qualify if…
- Diagnosis of Autism or autism spectrum disorder
- Presence of any indicators of trauma, neuromuscular influence or neurogenic influence as identified by using the Toe Walking Tool
Where it is running
- Shriners Hospitals for Children — Sacramento, California, United States
- Shriners Hospitals for Children — Chicago, Illinois, United States
- Shriners Hospitals for Children — Lexington, Kentucky, United States
- Shriners Hospitals for Children — Portland, Oregon, United States
- Shriners Hospitals for Children — Philadelphia, Pennsylvania, United States
- Shriners Hospitals for Children — Greenville, South Carolina, United States
- Shriners Hospitals for Children — Salt Lake City, Utah, United States
- Shriners Children's Spokane — Spokane, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.